You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 8, 2025

Details for Patent: 10,968,453


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,968,453 protect, and when does it expire?

Patent 10,968,453 protects QALSODY and is included in one NDA.

This patent has sixty-four patent family members in twenty-nine countries.

Summary for Patent: 10,968,453
Title:Compositions for modulating SOD-1 expression
Abstract:Disclosed herein are antisense compounds and methods for decreasing SOD-1 mRNA and protein expression. Such methods, compounds, and compositions are useful to treat, prevent, or ameliorate SOD-1 associated diseases, disorders, and conditions. Such SOD-1 associated diseases include amyotrophic sclerosis (ALS).
Inventor(s):Swayze Eric E.
Assignee:Biogen MA Inc.
Application Number:US16849583
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

United States Patent 10,968,453: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,968,453, titled "COMPOSITIONS FOR MODULATING SOD-1 EXPRESSION," is a significant patent in the field of biotechnology, particularly in the area of RNA therapeutics. This patent, assigned to Ionis Pharmaceuticals, Inc., covers innovative compositions and methods for modulating the expression of the superoxide dismutase 1 (SOD-1) gene, which is implicated in various neurological disorders.

Patent Overview

Title and Description

The patent titled "COMPOSITIONS FOR MODULATING SOD-1 EXPRESSION" focuses on the development of gapmer oligonucleotides designed to modulate the expression of the SOD-1 gene. These oligonucleotides are intended for the treatment of diseases associated with SOD-1, such as amyotrophic lateral sclerosis (ALS)[5].

Expiration Date

The expiration date of the patent is crucial for understanding the timeline during which the patent holder has exclusive rights. Typically, U.S. patents expire 20 years from the earliest filing date of the application. However, specific expiration dates can be found in detailed patent records or through databases like DrugPatentWatch[2].

Scope of the Patent

Claims

The patent includes multiple claims that define the scope of the invention. These claims can be categorized into several types:

Independent Claims

These claims stand alone and define the broadest scope of the invention. For example, claims might cover the composition of the gapmer oligonucleotides, their structure, and the specific sequences that target SOD-1.

Dependent Claims

These claims build upon the independent claims and provide additional details or limitations. They might specify particular aspects of the oligonucleotides, such as their length, the presence of specific nucleotides, or the method of administration.

Method Claims

These claims describe the methods of using the compositions to modulate SOD-1 expression. This could include methods of administration, dosing regimens, and treatment protocols.

Claim Analysis

To understand the full scope of the patent, it is essential to analyze each claim. Here are some key points to consider:

  • Claim Language: The language used in the claims is critical. Terms such as "comprising," "consisting of," and "consisting essentially of" have different implications for the scope of the claim.
  • Claim Dependencies: Dependent claims often narrow the scope of the independent claims but can also add specificity that might be crucial for distinguishing the invention from prior art.
  • Claim Charts: While not required by the USPTO, claim charts can be useful tools for visualizing the relationship between claims and identifying potential areas of infringement[4].

Patent Landscape

Prior Art and Related Patents

Understanding the prior art and related patents is essential for assessing the novelty and non-obviousness of the invention. Tools like the USPTO's Patent Public Search and the Common Citation Document (CCD) can help identify prior art cited by multiple patent offices, ensuring that the invention is distinct from existing technologies[1].

Global Dossier

The Global Dossier service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. This can help in identifying the patent family for a specific application and understanding how different jurisdictions have treated similar inventions[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), is crucial for determining if similar inventions have been patented abroad. This helps in understanding the global patent landscape and potential territorial limitations[1].

Economic and Strategic Implications

Patent Assignment and Ownership

The economic implications of the patent can be understood by analyzing patent assignment data. The USPTO provides detailed information on patent assignments and changes in ownership, which can indicate the commercial value and strategic importance of the patent[3].

Market Impact

The patent's impact on the market can be significant, especially in the biotechnology sector where intellectual property is a key driver of innovation. The exclusive rights granted by the patent can influence market entry for generic or competing products, affecting pricing and accessibility of treatments.

Regulatory and Legal Considerations

Patent Quality

The USPTO has initiatives to improve patent quality, including the Enhanced Patent Quality Initiative. This ensures that patents, like 10,968,453, meet statutory requirements for novelty, clarity, and non-obviousness. A consistent definition of patent quality, as recommended by the GAO, helps in maintaining high standards[4].

Litigation and Enforcement

The patent's validity and enforceability can be tested through litigation. Stakeholders often define a quality patent as one that would be upheld if challenged in a lawsuit. The USPTO's measures for patent quality, such as compliance rates for statutory requirements, are crucial in this context[4].

Key Takeaways

  • Scope and Claims: The patent covers specific compositions and methods for modulating SOD-1 expression, with detailed claims defining the scope of the invention.
  • Patent Landscape: Understanding prior art, related patents, and global patent filings is essential for assessing the novelty and strategic value of the patent.
  • Economic Implications: The patent's economic value is reflected in its assignment history and market impact, particularly in the biotechnology sector.
  • Regulatory Considerations: Ensuring patent quality and compliance with statutory requirements is crucial for the patent's validity and enforceability.

FAQs

Q: What is the main focus of United States Patent 10,968,453?

A: The main focus of the patent is on compositions and methods for modulating the expression of the SOD-1 gene using gapmer oligonucleotides.

Q: How can I find the expiration date of the patent?

A: The expiration date can be found in detailed patent records or through databases like DrugPatentWatch.

Q: What tools are available for searching prior art related to this patent?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) are available for searching prior art.

Q: How does the patent impact the market for treatments related to SOD-1?

A: The patent grants exclusive rights, which can influence market entry for generic or competing products, affecting pricing and accessibility of treatments.

Q: What initiatives does the USPTO have to ensure patent quality?

A: The USPTO has the Enhanced Patent Quality Initiative and follows recommendations from the GAO to ensure patents meet statutory requirements for novelty, clarity, and non-obviousness.

Sources

  1. USPTO: Search for patents - USPTO. Retrieved from https://www.uspto.gov/patents/search
  2. DrugPatentWatch: Drugs covered by patent 10,968,453. Retrieved from https://www.drugpatentwatch.com/p/patent/10968453
  3. USPTO: Patent and patent application Claims data (Stata (.dta) and MS Excel (.csv)). Retrieved from https://developer.uspto.gov/product/patent-and-patent-application-claims-data-stata-dta-and-ms-excel-csv
  4. GAO: Intellectual Property: Patent Office Should Define Quality, Reassess Time Allotted for Examination. Retrieved from https://www.gao.gov/products/gao-16-490
  5. Ionis Pharmaceuticals: COMPOSITIONS FOR MODULATING SOD-1 EXPRESSION. Retrieved from https://ir.ionis.com/static-files/57b8b6db-9f04-43b1-ac4e-163694c318fa

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,968,453

Showing 1 to 1 of 1 entries

International Family Members for US Patent 10,968,453

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 3126499 ⤷  Try for Free CR 2024 00038 Denmark ⤷  Try for Free
European Patent Office 3126499 ⤷  Try for Free 301293 Netherlands ⤷  Try for Free
European Patent Office 3126499 ⤷  Try for Free LUC00359 Luxembourg ⤷  Try for Free
European Patent Office 3126499 ⤷  Try for Free PA2024531 Lithuania ⤷  Try for Free
European Patent Office 3126499 ⤷  Try for Free 2024C/538 Belgium ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 5 of 5 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.